跳到主要內容

很遺憾,我們無法支援你的瀏覽器。如果可以,請升級到新版本,或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更新版本。如果無法升級,而且需要支援,請將你的回饋寄給我們。

我們衷心感謝你對這個新體驗的回饋。告訴我們你的想法 打開新的分頁/視窗

Elsevier
與我們共同出版
Helping to Mitigate Risk in GenAI Tools for CDS
Whitepaper

Helping to Mitigate Risk in GenAI Tools for CDS

Elsevier uses a robust evaluation framework to assess ClinicalKey AI, its generative AI-powered clinical decision support tool, for efficacy and bias. Generative AI technologies hold immense potential to tackle challenges from boosting operational efficiencies to enhancing clinical decision support. However, their true value can only be realized when they are used safely, responsibly, and ethically. Read the white paper to gain insights into:

  • The importance of rigorous evaluation frameworks for generative AI in healthcare

  • Strategies to mitigate risks, including AI “hallucinations” and potential biases

  • The methodology used by Elsevier to evaluate the performance of ClinicalKey AI

Helping to Mitigate Risk in GenAI Tools for CDS

Helping to Mitigate Risk in GenAI Tools for CDS

Download here  打開新的分頁/視窗